Article info
Ovarian Cancer
Pegylated Liposomal Doxorubicin and Gemcitabine in a Fixed Dose Rate Infusion for the Treatment of Patients With Poor Prognosis of Recurrent Ovarian Cancer: A Phase Ib Study
- Address correspondence and reprint requests to Guillermo Crespo, PhD, Hospital Universitario Central de Asturias, C/ Celestino Villamil s/n, Oviedo 33005, Spain. E-mail: gcrespoherrero{at}hotmail.com.
Citation
Pegylated Liposomal Doxorubicin and Gemcitabine in a Fixed Dose Rate Infusion for the Treatment of Patients With Poor Prognosis of Recurrent Ovarian Cancer: A Phase Ib Study
Publication history
- Received September 14, 2010
- First published April 1, 2011.
Online issue publication
April 01, 2011
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright © 2011 by IGCS and ESGO